Taylor Devices, Inc. — FY2024 Form 10-K Summary
Reporting period: Fiscal year ended May 31, 2024; comparisons are with the fiscal year ended May 31, 2023. This is an annual report, not a calendar-year 2023 or standalone Q4 report. Taylor Devices designs and manufactures shock-absorption, rate-control and energy-storage products, serving industrial, structural, and aerospace/defense markets.
Financial performance
| Metric | FY2024 | FY2023 | Change |
|---|---|---|---|
| Net sales | $44.58 million | $40.20 million | +11% |
| Gross profit / margin | $20.84 million / 46.7% | $16.95 million / 42.2% | Margin +4.5 percentage points |
| Operating income | $9.48 million | $6.81 million | +39% |
| Net income | $9.00 million | $6.29 million | +43% |
| Diluted EPS | $2.58 | $1.77 | +$0.81 |
| Net cash from operations | $13.22 million | $7.71 million | +$5.51 million |
| Capital expenditures | $1.15 million | $3.36 million | -$2.21 million |
Gross margin improved as price increases helped recover higher materials and labor costs, alongside increased volume and continuous-improvement benefits. Operating income also benefited from lower R&D spending; SG&A rose 21% to $10.97 million, primarily due to personnel costs. Net interest income increased to $1.43 million from $0.70 million, reflecting higher short-term investment balances. The effective tax rate was 17.6%, versus 16.2%.
Markets, balance sheet and liquidity
- Aerospace/defense sales rose 71% to $26.68 million and represented 60% of revenue. Structural sales fell 30% to $14.41 million; industrial sales fell 12% to $3.50 million.
- U.S. sales increased 18% and accounted for 86% of revenue. Asia sales decreased 55% and represented 4% of revenue.
- At May 31, 2024, cash and cash equivalents were $2.83 million and short-term investments were $28.13 million, compared with $3.58 million and $24.51 million, respectively, a year earlier. Total assets were $63.08 million; stockholders’ equity was $51.25 million.
- There was no outstanding balance on the $10 million demand line of credit. Current assets were $48.77 million and current liabilities $11.83 million. Management believes cash, operating cash flows and borrowing capacity can fund operations and capital improvements for the next 12 months. The line is subject to annual renewal and the bank is not committed to lend.
- Inventory increased 31% to $9.09 million, including $6.41 million of work in process. Inventory turnover declined to 3.0 from 3.5; the company disposed of $791,000 of obsolete inventory, versus $322,000 in FY2023.
- Backlog was $33.1 million across 134 open orders, versus $32.5 million across 134 orders. Management expects to recognize most backlog revenue in FY2025 and the remainder in FY2026.
Material changes, outlook and risks
- Revenue mix shifted substantially toward aerospace/defense and away from structural projects. Projects in process during the year numbered 39, versus 52 in FY2023; management cautions that project timing and period-to-period results may not predict future performance.
- Product R&D expense fell 65% to $388,000 after completion of the Taylor Damped Moment Frame project. Government-funded and customer-funded R&D were $818,000 and $477,000, respectively.
- The company repurchased 459,015 shares—about 13% of shares outstanding at the transaction date—at $19.92 per share, for approximately $9.14 million. It paid no cash dividend and expects to retain cash for working capital.
- Capital expenditure commitments were approximately $1.36 million. The company also acquired Pumpkin Mounts intellectual property for $300,000.
- Four customers represented approximately 40% of FY2024 sales; the largest represented 21%. Losing major customers could materially harm results. Federal government contracts may be terminated at the government’s election, and reduced defense spending could adversely affect the business.
- Other stated risks include variable order timing and demand, competition and pricing pressure, technological change, and estimation uncertainty in long-term contract costs and revenue. The auditor identified contract cost estimates/revenue recognition and inventory valuation as critical audit matters.
- A third-party defendant in litigation concerning alleged construction/design defects at 432 Park Avenue, the company denies the allegations. Discovery remains ongoing; the company says it cannot determine the likelihood of an unfavorable outcome or quantify a potential loss.
- No formal earnings or sales guidance is provided. Management’s stated near-term outlook is based on backlog conversion and its assessment of available liquidity.
Important facts for investors to verify
- Whether the $33.1 million backlog converts on the expected FY2025–FY2026 schedule and at anticipated margins.
- How sustainable the higher gross margin is, given input costs, pricing, product mix, and SG&A growth.
- Customer concentration, especially the largest customer’s 21% revenue share, and the volatility of structural and defense-related demand.
- Inventory growth, obsolescence reserves and write-offs, and the assumptions behind long-term contract cost estimates.
- Developments in the 432 Park Avenue litigation and any potential financial exposure.
- Liquidity and capital allocation after the significant share repurchase, including renewal and availability of the demand credit line.